2026 Life Sciences Manufacturing Outlook

Life sciences manufacturers are stepping into 2026 with the same pressures they’ve felt for years—tight regulatory expectations, growing product complexity, and persistent workforce strain—but the margin for slow, manual processes is disappearing. Many teams are still tethered to inflexible batch records, cumbersome documentation, and delayed quality insights that reveal problems only after they occur. What’s different now is that AI is no longer theoretical. It’s moving into day‑to‑day operations, and the organizations that will advance are those able to modernize without letting compliance slow their progress. Discover what truly shifted in 2025 and how those changes should shape operational priorities in 2026.

Watch the full webinar to learn practical ways to de-risk AI adoption, streamline execution in validated environments, and shorten release cycles while maintaining regulatory confidence.